Novel Mutations in the FLT3 Gene in Adult Patients With Refractory Acute Myeloid Leukemia

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403580
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Profile of Quizartinib for the Treatment of Adult Patients With Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date

Cancer Management and Research
Oncology
2020English

Identification of FLT3 and NPM1 Mutations in Patients With Acute Myeloid Leukaemia

Asian Pacific Journal of Cancer Prevention
2019English

FLT3 Mutations in Canine Acute Lymphocytic Leukemia

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Differential Signaling of Flt3 Activating Mutations in Acute Myeloid Leukemia: A Working Model

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2011English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

Clinical Outcome of Patients With Acute Promyelocytic Leukemia and FLT3 Mutations

American Journal of Hematology
Hematology
2010English

FLT3-TKD Mutation in Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Correlation Analysis of P53 Protein Isoforms With NPM1/FLT3 Mutations and Therapy Response in Acute Myeloid Leukemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy